Evaluation of the Medicines and Healthcare products Regulatory Agency's introduction of a risk-proportionate approach for clinical trials: An analysis of 4617 applications assessed between September 2023 and August 2024. - Manfrin A; Lee K; Cacou C; Pound J; Harnden A; Raine J; Pirmohamed M (British journal of clinical pharmacology, 2026)